Bank of America
BOLD

Bank of America’s Boundless Bio BOLD Stock Holding History

Bank of America’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,758
Closed -$9.31K – 7002
2025
Q4 		$9.31K Buy
7,758
+19
+0.2% +$24 ﹤0.01% 6174
2025
Q3 		$9.52K Sell
7,739
-36
-0.5% -$42 ﹤0.01% 7212
2025
Q2 		$7.85K Sell
7,775
-7,519
-49% -$9.99K ﹤0.01% 7234
2025
Q1 		$23.1K Sell
15,294
-4,763
-24% -$9.87K ﹤0.01% 6935
2024
Q4 		$58.2K Buy
20,057
+9,005
+81% +$26.2K ﹤0.01% 6590
2024
Q3 		$38.4K Sell
11,052
-6,860
-38% -$24.9K ﹤0.01% 6616
2024
Q2 		$69.3K Buy
+17,912
New +$171K ﹤0.01% 6411

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Bank of America's BOLD Position: Q1 2026 in Review

Bank of America sold out of Boundless Bio (BOLD) in Q1 2026, closing a stake of 7,758 shares — an estimated $9.31K sold.

Bank of America first reported a position in BOLD in Q2 2024 and held it in 7 quarters. The position peaked at $69.3K in Q2 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • Bank of America reported no remaining Boundless Bio position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 7,758 Boundless Bio shares in Q1 2026, an estimated $9.31K.
  • Bank of America first reported a position in Boundless Bio in Q2 2024 and held it in 7 quarters.
  • Bank of America's Boundless Bio position peaked at $69.3K in Q2 2024.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.